(3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid CAS: 865233-35-8

CAS NO: 865233-35-8
(3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid
Chemical Name: (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid
Molecular Formula: C12H12O3
Formula Weight: 204.22
CAS No.: 865233-35-8
Description Review
Description

(3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid is a chemical compound that belongs to the family of phenolic acids. This product has gained significant interest in the scientific community due to its potential health benefits and therapeutic properties, including its ability to act as an antioxidant and anti-inflammatory agent.

Chemical name:

The chemical name of (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid is (3S)-3-(4-hydroxyphenyl)-4-hex-3-ynoic acid.

Molecular formula:

The molecular formula of this product is C12H10O3.

Formula weight:

The formula weight of (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid is 202.21 g/mol.

CAS No:

The CAS number for (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid is 865233-35-8.

Top ten keywords from Google and Synonyms:

  1. (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid
  2. CAS number 865233-35-8
  3. Phenolic acid
  4. Antioxidant
  5. Anti-inflammatory
  6. Health benefits
  7. Therapeutic properties
  8. (3S)-4-Hex-3-ynoic acid, 3-(4-hydroxyphenyl)-
  9. Hydroxycinnamic acid
  10. Tyrosol

Synonyms:

  1. (3S)-4-Hex-3-ynoic acid, 3-(4-hydroxyphenyl)-
  2. 4-Hex-3-ynoic acid, (3S)-3-(4-hydroxyphenyl)-
  3. Tyrosol
  4. Hydroxycinnamic acid
  5. 4-Hydroxycinnamic acid
  6. (E)-3-(4-Hydroxyphenyl)acrylic acid

Health benefits of this product:

(3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid has several health benefits due to its antioxidant and anti-inflammatory properties. It may help to reduce inflammation in the body, which can lead to a range of health problems such as cardiovascular disease, diabetes, and cancer. Additionally, it may act as an antioxidant and protect against oxidative damage caused by free radicals.

Potential effects:

(3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid may have various potential effects due to its chemical properties. It may act as an inhibitor of enzymes such as cyclooxygenase and lipoxygenase, which are involved in the production of inflammatory mediators. It may also act as an antioxidant and scavenge free radicals, which are responsible for oxidative damage to cells and tissues.

Product mechanism:

The exact mechanism of action of (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid is not fully understood. However, it is believed to work by inhibiting the activity of various enzymes involved in the production of inflammatory mediators. It may also act as an antioxidant and scavenge free radicals, which can cause cellular damage.

Safety:

(3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid is generally considered safe when used in accordance with recommended dosages. However, like any other chemical compound, it may cause adverse effects if ingested or applied in excessive amounts. It is important to follow dosing recommendations and safety precautions when using this product.

Side effects:

There are no major side effects reported for (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid. However, some individuals may experience mild side effects such as skin irritation or allergic reactions. If any adverse effects occur, discontinue use and seek medical attention immediately.

Dosing information:

The recommended dosage of (3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid varies depending on the intended use and application. It is important to follow dosing instructions carefully and consult with a healthcare professional before use.

Conclusion:

(3S)-3-(4-Hydroxyphenyl)-4-hexynoic acid is a promising compound that has shown potential health benefits and therapeutic properties, including its ability to act as an antioxidant and anti-inflammatory agent. While more research is needed to fully understand its mechanisms of action and potential uses, early studies have shown promising results. As with any medication, it is important to follow dosing instructions carefully and consult with a healthcare professional before use

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code